Leukocyte reduction in cardiovascular surgery.
Morris
S J
SJ
Pall Medical, Portsmouth, UK. Steve_Morris@Pall.com
D000818:Animals; D016063:Blood Loss, Surgical; D001921:Brain / Q000503:physiopathology; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass / Q000295:instrumentation; D004867:Equipment Design; D005374:Filtration; D006321:Heart / Q000503:physiopathology; D006324:Heart Arrest, Induced; D016027:Heart Transplantation; D006801:Humans; D020766:Intracranial Embolism / Q000517:prevention & control; D007431:Intraoperative Complications / Q000209:etiology / Q000517:prevention & control; D007962:Leukocytes / Q000378:metabolism; D008168:Lung / Q000503:physiopathology; D016040:Lung Transplantation; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion / Q000295:instrumentation / Q000379:methods; D023421:Models, Animal; D009206:Myocardium / Q000473:pathology; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D015427:Reperfusion Injury / Q000209:etiology / Q000517:prevention & control; D013396:Suction; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000517:prevention & control